Ozone-induced increase in exhaled 8-isoprostane in healthy subjects is resistant to inhaled budesonide
- 1 November 2002
- journal article
- clinical trial
- Published by Elsevier in Free Radical Biology & Medicine
- Vol. 33 (10) , 1403-1408
- https://doi.org/10.1016/s0891-5849(02)01084-5
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Exhaled 8-Isoprostane as an In Vivo Biomarker of Lung Oxidative Stress in Patients with COPD and Healthy SmokersAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosisThorax, 2000
- No Effect of Inhaled Budesonide on the Response to Inhaled Ozone in Normal SubjectsAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Increased 8-Isoprostane, a Marker of Oxidative Stress, in Exhaled Condensate of Asthma PatientsAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Ozone-induced lung function decrements do not correlate with early airway inflammatory or antioxidant responsesEuropean Respiratory Journal, 1999
- The isoprostanes: Unique bioactive products of lipid peroxidationProgress in Lipid Research, 1997
- Analysis of Induced Sputum after Air and Ozone Exposures in Healthy SubjectsEnvironmental Research, 1995
- Ozone-induced Increases in Substance P and 8-Epi-Prostaglandin F2α in the Airways of Human SubjectsAmerican Journal of Respiratory Cell and Molecular Biology, 1993
- A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.Proceedings of the National Academy of Sciences, 1990
- Ozone-induced Inflammation in the Lower Airways of Human SubjectsAmerican Review of Respiratory Disease, 1989